Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Mar 31, 2020 · 10-K · 275 days after period end · 0001477932-20-001711
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $136.52K | $226.49K |
| Net Income | -$4.20M | -$191.24K | -$476.98K | -$553.16K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Mar 31, 2020 · 275 d after period end
